The IL-10 receptor inhibits cell extrinsic signals necessary for STAT1-dependent macrophage accumulation during colitis
暂无分享,去创建一个
S. Snapper | A. Eran | Zeli Shen | B. Horwitz | N. Redhu | Ying Tang | James G. Fox | Anubhab Nandy | Izabel Patik | Shorouk El Sayed | Jonathan Glickman | Bin Bao | Naresh S. Redhu | Z. Shen
[1] Liqi Zhu,et al. The Deletion of IL-17A Enhances Helicobacter hepaticus Colonization and Triggers Colitis , 2022, Journal of inflammation research.
[2] S. Snapper,et al. CCR2 promotes monocyte recruitment and intestinal inflammation in mice lacking the interleukin-10 receptor , 2022, Scientific reports.
[3] Nadezhda T. Doncheva,et al. The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets , 2020, Nucleic Acids Res..
[4] J. Mar,et al. Investigating transcriptome-wide sex dimorphism by multi-level analysis of single-cell RNA sequencing data in ten mouse cell types , 2020, Biology of sex differences.
[5] D. Foell,et al. Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn’s disease , 2020, World journal of gastroenterology.
[6] S. Vermeire,et al. JAK–STAT pathway targeting for the treatment of inflammatory bowel disease , 2020, Nature Reviews Gastroenterology & Hepatology.
[7] G. Núñez,et al. Host–microbiota interactions in inflammatory bowel disease , 2020, Nature Reviews Immunology.
[8] G. Rogler. Efficacy of JAK inhibitors in Crohn’s Disease , 2019, Journal of Crohn's & colitis.
[9] A. Larochelle,et al. Commensal microbiota drive the functional diversification of colon macrophages , 2019, Mucosal Immunology.
[10] G. Matteoli,et al. Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD , 2019, Nature Reviews Gastroenterology & Hepatology.
[11] Eyal David,et al. IL-23–producing IL-10Rα–deficient gut macrophages elicit an IL-22–driven proinflammatory epithelial cell response , 2019, Science Immunology.
[12] S. Clare,et al. Alpha kinase 1 controls intestinal inflammation by suppressing the IL-12/Th1 axis , 2018, Nature Communications.
[13] T. Ohteki,et al. IFN-γ-dependent epigenetic regulation instructs colitogenic monocyte/macrophage lineage differentiation in vivo , 2018, Mucosal Immunology.
[14] C. Thomson,et al. Proinflammatory Role of Monocyte-Derived CX3CR1int Macrophages in Helicobacter hepaticus-Induced Colitis , 2017, Infection and Immunity.
[15] Rajsavi S. Anand,et al. Enhanced TH17 Responses in Patients with IL10 Receptor Deficiency and Infantile-onset IBD , 2017, Inflammatory bowel diseases.
[16] Eugenia G. Giannopoulou,et al. Interferon‐&ggr; Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF , 2017, Immunity.
[17] G. Gerber,et al. Macrophage dysfunction initiates colitis during weaning of infant mice lacking the interleukin-10 receptor , 2017, eLife.
[18] S. Snapper,et al. Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages , 2017, Science.
[19] S. Snapper,et al. Inhibition of Inflammatory Gene Transcription by IL-10 Is Associated with Rapid Suppression of Lipopolysaccharide-Induced Enhancer Activation , 2017, The Journal of Immunology.
[20] Johannes U. Mayer,et al. Tissue-Specific Differentiation of Colonic Macrophages Requires TGFβ Receptor Mediated Signalling , 2017, Mucosal Immunology.
[21] C. Klein,et al. Interleukin 1β Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency. , 2016, Gastroenterology.
[22] J. Samsom,et al. IL-10 control of CD11c+ myeloid cells is essential to maintain immune homeostasis in the small and large intestine , 2016, Oncotarget.
[23] S. Macdonald,et al. Differential Requirements for IL-17A and IL-22 in Cecal versus Colonic Inflammation Induced by Helicobacter hepaticus. , 2015, The American journal of pathology.
[24] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[25] P. Vogel,et al. IL-10 engages macrophages to shift Th17 cytokine dependency and pathogenicity during T cell-mediated colitis , 2014, Nature Communications.
[26] Timothy L. Tickle,et al. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. , 2014, The Journal of clinical investigation.
[27] C. Bain,et al. Macrophages in intestinal homeostasis and inflammation , 2014, Immunological reviews.
[28] C. Klein,et al. Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function. , 2014, Immunity.
[29] T. Decker,et al. The regulation of inflammation by interferons and their STATs , 2013, JAK-STAT.
[30] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[31] Ansuman T. Satpathy,et al. Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. , 2012, Immunity.
[32] J. Casanova,et al. Immunity to infection in IL‐17‐deficient mice and humans , 2012, European journal of immunology.
[33] G. Cheng,et al. Systematic identification of type I and type II interferon-induced antiviral factors , 2012, Proceedings of the National Academy of Sciences.
[34] C. Klein,et al. IL‐10 and IL‐10 receptor defects in humans , 2011, Annals of the New York Academy of Sciences.
[35] A. Fischer,et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis , 2011, The Journal of experimental medicine.
[36] F. Rieux-Laucat,et al. Defective IL10 Signaling Defining a Subgroup of Patients With Inflammatory Bowel Disease , 2011, The American Journal of Gastroenterology.
[37] N. Sebire,et al. Infant colitis—it's in the genes , 2010, The Lancet.
[38] J. Affourtit,et al. Cdcs1 a major colitis susceptibility locus in mice; Subcongenic analysis reveals genetic complexity , 2010, Inflammatory bowel diseases.
[39] M. Robinson,et al. A scaling normalization method for differential expression analysis of RNA-seq data , 2010, Genome Biology.
[40] A. Schäffer,et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. , 2009, The New England journal of medicine.
[41] Lionel B Ivashkiv,et al. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. , 2009, Immunity.
[42] G. Parmigiani,et al. Genome‐wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: Insights into distinctive pathogenesis , 2007, Inflammatory bowel diseases.
[43] L. Ivashkiv,et al. Role of STAT3 in Type I Interferon Responses , 2006, Journal of Biological Chemistry.
[44] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[45] L. Ivashkiv,et al. IFN-γ-Primed Macrophages Exhibit Increased CCR2-Dependent Migration and Altered IFN-γ Responses Mediated by Stat11 , 2005, The Journal of Immunology.
[46] R. Kiesslich,et al. Activation Pattern of Signal Transducers and Activators of Transcription (STAT) Factors in Inflammatory Bowel Diseases , 2005, The American Journal of Gastroenterology.
[47] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[48] J. Hampe,et al. Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease , 2002, Gut.
[49] Peter J. Murray,et al. Shaping Gene Expression in Activated and Resting Primary Macrophages by IL-101 , 2002, The Journal of Immunology.
[50] G. Stark,et al. Complex roles of Stat1 in regulating gene expression , 2000, Oncogene.
[51] H. Dickensheets,et al. Interleukin-10 Inhibits Expression of Both Interferon – and Interferon γ– Induced Genes by Suppressing Tyrosine Phosphorylation of STAT1 , 1999 .
[52] J M Ward,et al. Helicobacter hepaticus Triggers Colitis in Specific-Pathogen-Free Interleukin-10 (IL-10)-Deficient Mice through an IL-12- and Gamma Interferon-Dependent Mechanism , 1998, Infection and Immunity.
[53] R. Sartor,et al. Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice , 1998, Infection and Immunity.
[54] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[55] K. Rajewsky,et al. Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.